Страница 105

1. D. M. Kissen and H. G. Eysenck, “Personality in Male Lung Cancer Patients,”

Journal of Psychosomatic Research 6 (1962), 123.

2. T. Cox and C. MacKay, “Psychosocial Factors and Psychophysiological Mechanisms in the Aetiology and Development of Cancers,” Social Science and Medicine 16 (1982), 385.

3. R. Grossarth-Maticek et al., “Psychosocial Factors as Strong Predictors of Mortality from Cancer, Ischaemic Heart Disease and Stroke: The Yugoslav Prospective Study,” Journal of Psychosomatic Research 29, no. 2 (1985), 167–76.

4. C. B. Pert et al., “Neuropeptides and Their Receptors: A Psychosomatic Network,”

The Journal of Immunology 135, no. 2 (August 1985).

5. Candace Pert, Molecules of Emotion: Why You Feel the Way You Feel (New York: Touchstone, 1999), 22–23.

6. E. R. De Kloet, “Corticosteroids, Stress, and Ageing,” A

7. Rajesh K. Naz, Prostate: Basic and Clinical Aspects (Boca Raton: CRC Press 1997), 75.

8. J. K. Kiecolt-Glaser and R. Glaser, “Psychoneuroimmunology and Immunotoxicology: Implications for Carcinogenesis,” Psychosomatic Medicine 61

(1999), 271—72.

9. C. Tournier et al., “Requirement of JNK for Stress-Induced Activation of the Cytochrome c-Mediated Death Pathway,” Science 288 (5 May 2000), 870—74.

10. W. Jung and M. Irwin, “Reduction of Natural Killer Cytotoxic Activity in Major Depression: Interaction between Depression and Cigarette Smoking,”

Psychosomatic Medicine 61 (1999) 26,3–70.

11. H. Anisman et al., “Neuroimmune Mechanisms in Health and Disease: 2.

Disease,” Canadian Medical Association Journal 155, no. 8 (15 October 1996).